Horizon Pharma Plc – Strategy, SWOT and Corporate Finance Report
- Pages: 60
- Published: June 2019
- Report Code: MLPH243700FSA
Horizon Pharma Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company
Key Highlights
Horizon Pharma plc (Horizon Pharma) is a pharmaceutical company which develops and commercializes medical products for the treatment of pain, arthritis and inflammatory diseases. It markets medicines through its orphan, primary care and rheumatology business units. The company’s marketed products include Actimmune, Buphenyl, Duexis, Krystexxa, Migergot, Pennsaid 2%, Procysbi, Quinsair, Ravicti, Rayos and Vimovo. Horizon Pharma provides products and services to patients and healthcare professionals in the US. The company operates through offices in the US, Switzerland, the Netherlands and Germany. Horizon Pharma is headquartered in Dublin, Ireland.
Scope
Detailed information on Horizon Pharma Plc required for business and competitor intelligence needs
A study of the major internal and external factors affecting Horizon Pharma Plc in the form of a SWOT analysis
An in-depth view of the business model of Horizon Pharma Plc including a breakdown and examination of key business segments
News about Horizon Pharma Plc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Horizon Pharma Plc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Horizon Pharma Plc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Horizon Pharma Plcs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Acorda Therapeutics Inc
Sucampo Pharmaceuticals Inc
Orexigen Therapeutics Inc
Arena Pharmaceuticals Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.